Back in 2004, a popular arthritis drug called Vioxx was pulled off the market when studies showed daily long-term use could increase the risk of heart attack, stroke and death. “This was one of the ...

NEW ORLEANS (AP) — A new study gives some reassurance to arthritis sufferers who want pain relief but are worried about side effects. It finds that Celebrex, a drug similar to ones withdrawn 12 years ...

People who took a newer type of pain pill over a three-year period were less likely to develop polyps that could lead to colorectal cancer -- but at the expense of a higher risk of heart problems, new ...

A large study has produced reassuring evidence about a drug that millions of people use to alleviate pain from arthritis and other ailments. The study found no evidence that the drug Celebrex, or ...

Jeffrey Brown talks with health correspondent Susan Dentzer and Dr. John Reveille, director of the Division of Rheumatology at the University of Texas Health Science Center in Houston, about the ...

Pfizer's decision to continue selling the arthritis medication Celebrex -- which, based on the results of a national study announced on Friday, can triple patient risk for cardiovascular events ...

NEW ORLEANS — A new study gives some reassurance to arthritis sufferers who want pain relief but are worried about side effects. It finds that Celebrex, a drug similar to ones withdrawn 12 years ago ...

A study released today may mean that the painkiller celecoxib, once sold under the brand name Celebrex, is safer than prescription doses of ibuprofen or naproxen. That is if the study, which is ...

WASHINGTON — The Food and Drug Administration on Friday warned physicians to consider alternatives to the popular arthritis drug Celebrex because of new evidence that, like the similar drug Vioxx, ...

NEW YORK (Reuters) - Ads for Pfizer Inc.'s Celebrex arthritis drug are set to splash across U.S. television screens on Monday after more than a two-year hiatus, with an unusual upfront focus on its ...

After a long absence, Pfizer resumed DTC television advertising for Celebrex last month with a whopping 150-second spot that takes up an entire commercial break. Turning conventions of traditional ...